Carolina Muñoz-Corona1, Lizeth Guadalupe Gutiérrez-Canales2, Claudia Ortiz-Ledesma3, Liz Jovanna Martínez-Navarro3, Alejandro E Macías4, David Alejandro Scavo-Montes5, Eduardo Guaní-Guerra2,6. 1. Fellow of the General Directorate of Quality and Health Education, Ministry of Health, Mexico. 2. Department of Medicine, University of Guanajuato, Guanajuato, Mexico. 3. Department of Internal Medicine, Hospital Regional de Alta Especialidad del Bajío, León Guanajuato, Mexico. 4. Department of Medicine and Nutrition, University of Guanajuato, León, Mexico. 5. Hospital Estatal de Atención COVID-19, León Guanajuato, Mexico. 6. Department of Research, Hospital Regional de Alta Especialidad del Bajío, León Guanajuato, Mexico.
Abstract
OBJECTIVE: We aimed to describe the persistence of symptoms in coronavirus disease 2019 (COVID-19) and quality of life (QoL) among patients 90 days after their discharge from the hospital for infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and to determine differences in QoL domains concerning the absence or presence of persistent symptoms. METHODS: To measure QoL, we used a validated Spanish version of the 36-item Short Form Health Survey (SF-36). RESULTS: We included 141 patients. Ninety days after discharge, COVID-19 symptoms persisted in 107 patients (75.9%), with fatigue (55.3%) and joint pain (46.8%) being the most frequent. According to the SF-36, the role-physical score was the dimension with the lowest values (median score, 25; interquartile range, 0-75). Patients with joint pain, fatigue, and dyspnea had lower scores than patients without those symptoms, with 10 of the 13 evaluated SF-36 scales showing lower levels. CONCLUSION: Ninety days after hospital discharge from COVID-19 reference centers, most patients had persistent symptoms and had lower SF-36 scores than patients without symptoms. It is important to follow-up patients discharged from the hospital after SARS-CoV-2 infection, ideally through a post-COVID-19 health care clinic and rehabilitation program, to improve QoL in these patients.
OBJECTIVE: We aimed to describe the persistence of symptoms in coronavirus disease 2019 (COVID-19) and quality of life (QoL) among patients 90 days after their discharge from the hospital for infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and to determine differences in QoL domains concerning the absence or presence of persistent symptoms. METHODS: To measure QoL, we used a validated Spanish version of the 36-item Short Form Health Survey (SF-36). RESULTS: We included 141 patients. Ninety days after discharge, COVID-19 symptoms persisted in 107 patients (75.9%), with fatigue (55.3%) and joint pain (46.8%) being the most frequent. According to the SF-36, the role-physical score was the dimension with the lowest values (median score, 25; interquartile range, 0-75). Patients with joint pain, fatigue, and dyspnea had lower scores than patients without those symptoms, with 10 of the 13 evaluated SF-36 scales showing lower levels. CONCLUSION: Ninety days after hospital discharge from COVID-19 reference centers, most patients had persistent symptoms and had lower SF-36 scores than patients without symptoms. It is important to follow-up patients discharged from the hospital after SARS-CoV-2 infection, ideally through a post-COVID-19 health care clinic and rehabilitation program, to improve QoL in these patients.
Entities:
Keywords:
36-item Short Form Health Survey; Quality of life; coronavirus disease 2019; long COVID; persistent COVID-19 symptoms; severe acute respiratory syndrome coronavirus 2
Authors: R Méndez; V Balanzá-Martínez; S C Luperdi; I Estrada; A Latorre; P González-Jiménez; L Feced; L Bouzas; K Yépez; A Ferrando; D Hervás; E Zaldívar; S Reyes; M Berk; R Menéndez Journal: J Intern Med Date: 2021-03-13 Impact factor: 13.068
Authors: Francesco Landi; Angelo Carfì; Francesca Benvenuto; Vincenzo Brandi; Francesca Ciciarello; Maria Rita Lo Monaco; Anna Maria Martone; Carmen Napolitano; Francesco Pagano; Annamaria Paglionico; Luca Petricca; Sara Rocchi; Elisabetta Rota; Andrea Salerno; Marcello Tritto; Elisa Gremese; Roberto Bernabei Journal: Am J Prev Med Date: 2020-09-18 Impact factor: 5.043
Authors: Michael Maes; Haneen Tahseen Al-Rubaye; Abbas F Almulla; Dhurgham Shihab Al-Hadrawi; Kristina Stoyanova; Marta Kubera; Hussein Kadhem Al-Hakeim Journal: Int J Environ Res Public Health Date: 2022-08-19 Impact factor: 4.614